Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleGeneric Glucagon Approved for Severe Hypoglycemia.AuthorsJaklevic, Mary ChrisAbstractThe article reports that the generic glucagon product manufactured by Amphastar Pharmaceuticals for the treatment of severe hypoglycemia received drug approval from the U.S. Food and Drug Administration (FDA).PublicationJAMA: Journal of the American Medical Association, 2021, Vol 325, Issue 7, p613ISSN0098-7484Publication typeArticleDOI10.1001/jama.2021.0383